Teva Pharmaceutical Industries Limited (TEVA) Description, Stock price, News & Info

#ThinkSabio Latest News

TEVA – The European Medicines Agency Accepts Teva’s Marketing Authorization Application for Olanzapine Long-Acting Injectable (TEV-‘749) for the Treatment of Schizophrenia in Adults